Use of the fixed mandibular implant in oral cancer... (1998 study) Skip to main content
Retrospective Study Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 1998

Use of the fixed mandibular implant in oral cancer patients: a retrospective study.

August M, Bast B, Jackson M, Perrott D, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1998

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers reviewed medical records, X-rays, and follow-up exams of 18 oral cancer patients at one institution who had received a fixed mandibular implant (FMI), a device used to support a dental prosthesis in the jaw.

What They Found

In this retrospective review, 18 oral cancer patients with an FMI had no complications that required removing the implant, and only the rate of fistula formation (3 of 18) was statistically higher than in non-cancer controls (p equals 0.005). Seventeen of the 18 patients had squamous cell carcinoma, and the average XRT (radiation) dose to the mandible was 65.4 Gy. Sixteen of the implants had been loaded and were followed for an average of 16.4 months. Early complications included soft tissue overgrowth around pins (4 of 18), tongue ulceration (2 of 18), and wound dehiscence inside the mouth (2 of 18). Late complications included fistula formation (3 of 18), submental erythema (2 of 18), and persistent tissue overgrowth around pins (1 of 19, as written in the abstract). Fourteen of the 16 patients with a prosthesis reported better ability to eat solid foods and better articulation, and all 16 reported better aesthetics and more comfort in social settings. The average time from implant placement to prosthesis delivery was 3.6 months.

What This Means for Canadian Patients

This study looked at a jaw implant device in oral cancer patients, including those treated with radiation. HBO (hyperbaric oxygen) was given to only 2 of the 18 patients, and the abstract does not compare outcomes with or without it or say what it did, so it does not tell us whether HBOT affects results. The authors concluded the device was valuable for dental rehabilitation in this group, but this is a small review of 18 patients.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small, single-institution retrospective review of 18 patients with an average follow-up of 16.4 months, with no randomized comparison, and outcomes were drawn from medical records and recall exams.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Wound Care
Source Pubmed
PubMed ID 9496839
Year Published 1998
Journal Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
MeSH Terms Aged; Aged, 80 and over; Alveolar Bone Loss; Bone Plates; Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Cranial Irradiation; Cutaneous Fistula; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis Retention; Denture, Overlay; Female; Gingival Hyperplasia

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology